CVS Health Corp., adjusted current assets

US$ in millions

	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
As Reported
Current assets	68,645)	67,858)	65,682)	60,008)	56,369)
Adjustments
Add: Allowance for credit losses	407)	343)	333)	339)	358)
After Adjustment
Adjusted current assets	69,052)	68,201)	66,015)	60,347)	56,727)

Download chart

CVS Health Corp., adjusted total assets

US$ in millions

	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
As Reported
Total assets	253,215)	249,728)	228,275)	232,999)	230,715)
Adjustments
Add: Operating lease right-of-use asset (before adoption of FASB Topic 842)¹	—)	—)	—)	—)	—)
Add: Allowance for credit losses	407)	343)	333)	339)	358)
Less: Deferred income tax assets²	—)	—)	131)	—)	—)
After Adjustment
Adjusted total assets	253,622)	250,071)	228,477)	233,338)	231,073)

¹ Operating lease right-of-use asset (before adoption of FASB Topic 842). See details »

² Deferred income tax assets. See details »

Download chart

CVS Health Corp., adjusted total liabilities

US$ in millions

	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
As Reported
Total liabilities	177,485)	173,092)	156,960)	157,618)	161,014)
Adjustments
Add: Operating lease liability (before adoption of FASB Topic 842)¹	—)	—)	—)	—)	—)
Less: Deferred income tax liabilities²	3,806)	4,311)	3,880)	6,270)	6,794)
After Adjustment
Adjusted total liabilities	173,679)	168,781)	153,080)	151,348)	154,220)

¹ Operating lease liability (before adoption of FASB Topic 842). See details »

² Deferred income tax liabilities. See details »

Download chart

CVS Health Corp., adjusted total CVS Health shareholders’ equity

US$ in millions

	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
As Reported
Total CVS Health shareholders’ equity	75,560)	76,461)	71,015)	75,075)	69,389)
Adjustments
Less: Net deferred income tax assets (liabilities)¹	(3,806)	(4,311)	(3,749)	(6,270)	(6,794)
Add: Allowance for credit losses	407)	343)	333)	339)	358)
Add: Noncontrolling interests	170)	175)	300)	306)	312)
After Adjustment
Adjusted total shareholders’ equity	79,943)	81,290)	75,397)	81,990)	76,853)

¹ Net deferred income tax assets (liabilities). See details »

Download chart

CVS Health Corp., adjusted capitalization table

US$ in millions

	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
As Reported
Short-term debt	2,119)	200)	—)	—)	—)
Current portion of long-term debt	3,624)	2,772)	1,778)	4,205)	5,440)
Long-term debt, excluding current portion	60,527)	58,638)	50,476)	51,971)	59,207)
Total reported debt	66,270)	61,610)	52,254)	56,176)	64,647)
Total CVS Health shareholders’ equity	75,560)	76,461)	71,015)	75,075)	69,389)
Total reported capital	141,830)	138,071)	123,269)	131,251)	134,036)
Adjustments to Debt
Add: Operating lease liability (before adoption of FASB Topic 842)¹	—)	—)	—)	—)	—)
Add: Current portion of operating lease liabilities²	1,751)	1,741)	1,678)	1,646)	1,638)
Add: Long-term operating lease liabilities³	14,899)	16,034)	16,800)	18,177)	18,757)
Adjusted total debt	82,920)	79,385)	70,732)	75,999)	85,042)
Adjustments to Equity
Less: Net deferred income tax assets (liabilities)⁴	(3,806)	(4,311)	(3,749)	(6,270)	(6,794)
Add: Allowance for credit losses	407)	343)	333)	339)	358)
Add: Noncontrolling interests	170)	175)	300)	306)	312)
Adjusted total shareholders’ equity	79,943)	81,290)	75,397)	81,990)	76,853)
After Adjustment
Adjusted total capital	162,863)	160,675)	146,129)	157,989)	161,895)

¹ Operating lease liability (before adoption of FASB Topic 842). See details »

² Current portion of operating lease liabilities. See details »

³ Long-term operating lease liabilities. See details »

⁴ Net deferred income tax assets (liabilities). See details »

Download chart

CVS Health Corp., adjusted net income attributable to CVS Health

US$ in millions

12 months ended:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
As Reported
Net income attributable to CVS Health	4,614)	8,344)	4,149)	7,910)	7,179)
Adjustments
Add: Deferred income tax expense (benefit)¹	(572)	(676)	(2,075)	(428)	(564)
Add: Increase (decrease) in allowance for credit losses	64)	10)	(6)	(19)	39)
Less: Loss from discontinued operations, net of tax	—)	—)	—)	—)	(9)
Add: Other comprehensive income (loss), net of tax	177)	967)	(2,430)	(449)	395)
Add: Comprehensive income (loss), net of tax, attributable to noncontrolling interest	(28)	24)	16)	(12)	13)
After Adjustment
Adjusted net income	4,255)	8,669)	(346)	7,002)	7,071)

¹ Deferred income tax expense (benefit). See details »

Download chart

CVS Health Corp. (NYSE:CVS)

Adjustments to Financial Statements